DUBLIN--(BUSINESS WIRE)-- Research and Markets (http://www.researchandmarkets.com/research/ft27lp/animal) has announced the addition of Jain PharmaBiotech's new report "Animal Biotechnology - Technologies, Markets and Companies" to their offering. This report describes and evaluates animal biotechnology and its application in veterinary medicine and pharmaceuticals as well as improvement in food production. Knowledge of animal genetics is important in the application of biotechnology to manage genetic disorders and improve animal breeding. Genomics, proteomics and bioinformatics are also being applied to animal biotechnology. Transgenic technologies are used for improving milk production and the meat in farm animals as well as for creating models of human diseases. Transgenic animals are used for the production of proteins for human medical use. Biotechnology is applied to facilitate xenotransplantation from animals to humans. Genetic engineering is done in farm animals and nuclear transfer technology has become an important and preferred method for cloning animals.There is discussion of in vitro meat production by culture Biotechnology has potential applications in the management of several animal diseases such as foot-and-mouth disease, classical swine fever, avian flu and bovine spongiform encephalopathy. The most important biotechnology-based products consist of vaccines, particularly genetically engineered or DNA vaccines. Gene therapy for diseases of pet animals is a … Continue reading →

By Prachiti Dalvi Structure of Codeine Codeine is an opioid pain medication; but if you are a poor metabolizer of a particular enzyme (CYP2D6), you will experience no pain relief from this drug. However, if your doctor could administer something called pharmacogenetic testing, she would know to simply give you morphine (an active metabolite of codeine) instead. For now, this kind of testing isnt available. Mary Relling, PharmD Mary V. Relling, PharmD, the Chair of Pharmaceutical Sciences at St. Judes Children Hospital spoke about the need to implement pharmacogenetic testingon Thursday, January 10. A number of tests have recently emerged that are ready for prime time. When we know that some drugs may have adverse effects for people with particular genetic phenotypes, it is unethical to prescribe these drugs without knowing the patients genetic status. However, Relling said there are a number of barriers to integrating pharmacogenetic tests into clinical care: fragmentation of our healthcare system, a focus on sick-care rather than disease prevention, a lack of evidence for clinical utility or cost-effectiveness, complex underlying lab results, and a lack of a centralized system for recording patient information. The best way to break through these barriers is to conduct testing … Continue reading →

Join Walking Mountains Science Center for a discussion on the Science Behind Stem Cell Treatment for Joint Pain on Jan. 16 at 6:30 p.m. ThriveMD medical director Scott Brandt will discuss how stem cells carry huge potential to restore an active and pain-free life. Autologous (self-derived adult) stem cell therapy is one of the newest and most innovative avenues in regenerative medicine. Brandt will walk attendees through the minimally invasive procedure that works to relieve the pain and limitations of damaged joint cartilage without resorting to an invasive joint replacement surgery. The procedure involves harvesting a patient's own stem cells found in fat tissue, most often from the abdominal region. The tissue is then prepared in a cell-processing laboratory and injected into the ailing joint an hour later, using fluoroscopic guidance. Once injected, the cells can sense proteins that have been generated from cartilage damage. In response, these cells have the ability to make chondrocytes, which are the type of cells found in healthy cartilage. Then, through chondrogenesis (cartilage cell division), the damaged cartilage can be replaced with healthy cartilage tissue. Brandt will also discuss the results he is seeing with autologous stem cell therapy and why he prefers using … Continue reading →